- Recommendation ID
- DG50/01
- Question
Further research is recommended on:
• the impact of LiverMultiScan test results on decisions about care, such as the decision to do a liver biopsy, or on adherence to lifestyle interventions (see section 3.5)
• the test accuracy of LiverMultiScan compared with biopsy, or the prognostic ability of LiverMultiScan to predict clinical outcomes (see section 3.19).- Any explanatory notes
(if applicable)
Source guidance details
- Comes from guidance
- MRI-based technologies for assessing non-alcoholic fatty liver disease
- Number
- DG50
- Date issued
- January 2023
Other details
| Is this a recommendation for the use of a technology only in the context of research? | No |
| Is it a recommendation that suggests collection of data or the establishment of a register? | No |
| Last Reviewed | 31/01/2023 |